Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 22-week Randomized, Cross-over Study Comparing the Effects of Quinapril and Quinapril Plus Alpha-lipoic Acid (ALA) on Patients With Diabetes Mellitus and Hypertension

NCT00795262 is registered in ClinicalTrials.gov with InVasc Therapeutics, Inc. as lead sponsor.

NCT NCT00795262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00795262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 22-week Randomized, Cross-over Study Comparing the Effects of Quinapril and Quinapril Plus Alpha-lipoic Acid (ALA) on Patients With Diabetes Mellitus and Hypertension
Lead sponsor
InVasc Therapeutics, Inc.
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2008
Completion date
July 31, 2009
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, hypertension